UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048229
Receipt number R000054954
Scientific Title Epidemiological studies on the relationship between age, sensorineural hearing loss, and the distribution of blood NAD+ levels
Date of disclosure of the study information 2022/07/02
Last modified on 2023/07/03 09:15:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Epidemiological studies on the relationship between age, sensorineural hearing loss, and the distribution of blood NAD+ levels

Acronym

Epidemiological studies on the relationship between age, sensorineural hearing loss, and the distribution of blood NAD+ levels

Scientific Title

Epidemiological studies on the relationship between age, sensorineural hearing loss, and the distribution of blood NAD+ levels

Scientific Title:Acronym

Epidemiological studies on the relationship between age, sensorineural hearing loss, and the distribution of blood NAD+ levels

Region

Japan


Condition

Condition

sensorineural hearing loss

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the distribution of blood NAD+ level according to age and presence of sensorineural hearing loss such as age-related hearing loss and sudden hearing loss.

Basic objectives2

Others

Basic objectives -Others

Epidemiological survey

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Blood NAD+ levels in healthy subjects without hearing loss in 50s, in patients with sudden hearing loss (unilateral severe) in 50s, in patients with bilateral severe and advanced hearing loss in 80 years of age and older, and in patients without bilateral severe and advanced hearing loss in 80 years of age and older.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Healthy person without hearing loss in 50s
(2) Patients in 50s with sudden hearing loss (unilateral severe)
3) Patients in 80 years of age and older with bilateral severe or profound hearing loss
4) Patients in 80 years of age and older with no bilateral severe or profound hearing loss
5) Patients who can abstain from food in the morning and can visit the clinic in the morning.
(6) Patients who give consent to participate in the study.

Key exclusion criteria

(1) Patients with hearing loss due to factors unrelated to aging, such as trauma or hearing loss due to complications from other diseases
(2) Patients taking nicotinamide mononucleotide (NMN)

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Hideaki
Middle name
Last name Sakata

Organization

Kawagoe Otology Institute

Division name

Division of Otorhinolaryngology

Zip code

350-1122

Address

Kawagoe Ear Institute, Division of Otorhinolaryngology, Kawagoe Mine Medical Center, 103 Wakitacho, Kawagoe, Saitama

TEL

049-226-3387

Email

sakata@jikagaku.jp


Public contact

Name of contact person

1st name Hideaki
Middle name
Last name Sakata

Organization

Kawagoe Otology Institute

Division name

Division of Otorhinolaryngology

Zip code

350-1122

Address

Kawagoe Ear Institute, Division of Otorhinolaryngology, Kawagoe Mine Medical Center, 103 Wakitacho,

TEL

049-226-3387

Homepage URL


Email

sakata@jikagaku.jp


Sponsor or person

Institute

Kawagoe Otology Institute,Division of Otorhinolaryngology

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The clinical research ethical review board of Shido. Inc.

Address

1015, 1-9-7 Kitashinagawa Shinagawa-ku Tokyo Japan 140-0001

Tel

03-4500-5075

Email

info@shido.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 07 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 06 Month 29 Day

Date of IRB

2022 Year 07 Month 01 Day

Anticipated trial start date

2022 Year 07 Month 02 Day

Last follow-up date

2023 Year 04 Month 30 Day

Date of closure to data entry

2023 Year 04 Month 30 Day

Date trial data considered complete

2023 Year 05 Month 15 Day

Date analysis concluded

2023 Year 05 Month 31 Day


Other

Other related information

Observational Study


Management information

Registered date

2022 Year 07 Month 02 Day

Last modified on

2023 Year 07 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054954


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name